Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

ONCY

Oncolytics Biotech (ONCY)

Oncolytics Biotech Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ONCY
일자시간출처헤드라인심볼기업
2024/03/0806:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2024/03/0603:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2024/03/0502:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2024/02/2903:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2024/02/1422:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2024/01/0922:44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2024/01/0503:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/12/0800:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/11/1003:21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/11/1003:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/11/0403:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/11/0400:18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/11/0400:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/10/2401:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/10/2401:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/10/2104:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/10/1702:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/09/2701:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/09/2621:00PR Newswire (US)THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTSNASDAQ:ONCYOncolytics Biotech Inc
2023/09/2006:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/09/0701:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/08/1422:49Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/08/1421:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/08/0504:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/08/0503:57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
2023/06/2222:23Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
2023/06/0520:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
2023/05/2700:43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
2023/05/2619:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
2023/05/1204:30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
 검색 관련기사 보기:NASDAQ:ONCY